Literature DB >> 26282339

Factors associated with illicit methadone injecting in a Canadian setting.

Devin Tucker1, M-J Milloy1,2, Kanna Hayashi1,2, Paul Nguyen1,2, Thomas Kerr1,2, Evan Wood1,2.   

Abstract

BACKGROUND AND OBJECTIVES: While methadone is well established as an evidence-based treatment for opioid use disorder, safety concerns persist regarding its diversion. The authors examine the prevalence of and risk factors associated with injection of methadone in an urban population.
METHODS: Between December 2005 and November 2013, data were derived from two open prospective studies of persons who inject drugs (PWID) in Vancouver, Canada. Generalized estimating equations (GEE) logistic regression was used to determine factors independently associated with illicit methadone injecting.
RESULTS: During the study, 1911 individuals (34% women) were recruited; 134 (7%) participants reported methadone injecting at least once. In multivariable analysis, Caucasian ethnicity [adjusted odds ratio (AOR) = 1.90, 95% confidence interval (CI) = 1.20-3.00]; homelessness (AOR = 1.46, 95% CI = 1.09-1.95); drug dealing (AOR = 2.10, 95% CI = 1.50-2.93); ≥daily heroin injection (AOR = 1.57, 95% CI = 1.08-2.26); ≥daily crack smoking (AOR = 2.06, 95% CI = 1.44-2.95); being a victim of violence (AOR = 1.48, 95% CI = 1.04-2.12); and non-fatal overdose (AOR = 1.67, 95% CI = 1.67 (1.00-2.79) were independently and positively associated with methadone injection; female gender (AOR = 0.47, 95% CI = 0.30-0.75) was negatively associated. DISCUSSION AND
CONCLUSIONS: The diversion of methadone for illicit injection in this urban setting was associated with several markers of addiction severity and other health and social vulnerabilities. SCIENTIFIC SIGNIFICANCE: These findings underscore the need to ensure methadone accessibility while limiting diversion-related risk. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282339      PMCID: PMC4576827          DOI: 10.1111/ajad.12257

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  34 in total

1.  Methadone is safe for treating hospitalized patients with severe pain.

Authors:  Y Shir; G Rosen; A Zeldin; E M Davidson
Journal:  Can J Anaesth       Date:  2001-12       Impact factor: 5.063

2.  Illicit use of methadone among i.v. drug users in Montreal.

Authors:  P Lauzon; J Vincelette; J Bruneau; F Lamothe; N Lachance; M Brabant; J Soto
Journal:  J Subst Abuse Treat       Date:  1994 Sep-Oct

3.  A review of methadone deaths between 2001 and 2005 in Victoria, Australia.

Authors:  Jennifer L Pilgrim; Michael McDonough; Olaf H Drummer
Journal:  Forensic Sci Int       Date:  2013-02-16       Impact factor: 2.395

4.  The source of methadone in overdose deaths in Western Virginia in 2004.

Authors:  Melissa B Weimer; P Todd Korthuis; George S Behonick; Martha J Wunsch
Journal:  J Addict Med       Date:  2011-09       Impact factor: 3.702

5.  The "black box" of prescription drug diversion.

Authors:  James A Inciardi; Hilary L Surratt; Theodore J Cicero; Steven P Kurtz; Steven S Martin; Mark W Parrino
Journal:  J Addict Dis       Date:  2009-10

6.  Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.

Authors:  Lianping Ti; M-J Milloy; Kate Shannon; Annick Simo; Robert S Hogg; Sylvia Guillemi; Julio Montaner; Thomas Kerr; Evan Wood
Journal:  Sex Transm Infect       Date:  2014-02-12       Impact factor: 3.519

Review 7.  The role of methadone in cancer pain treatment--a review.

Authors:  W Leppert
Journal:  Int J Clin Pract       Date:  2009-07       Impact factor: 2.503

8.  Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs.

Authors:  Theresa E Perlis; Don C Des Jarlais; Samuel R Friedman; Kamyar Arasteh; Charles F Turner
Journal:  Addiction       Date:  2004-07       Impact factor: 6.526

Review 9.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia.

Authors:  Rachel Humeniuk; Robert Ali; Catherine McGregor; Shane Darke
Journal:  Addiction       Date:  2003-04       Impact factor: 6.526

View more
  4 in total

1.  Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California.

Authors:  Johnathan K Zhao; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2019-10-14       Impact factor: 2.164

2.  Social determinants of ethno-racial inequalities in substance use: a decomposition of national survey data.

Authors:  Alexandra Blair; Arjumand Siddiqi
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-04-28       Impact factor: 4.519

Review 3.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

4.  Factors associated with health-related cannabis use intentions among a community sample of people who inject drugs in Los Angeles and San Francisco, CA 2016 to 2018.

Authors:  Rachel Carmen Ceasar; Alex H Kral; Kelsey Simpson; Lynn Wenger; Jesse L Goldshear; Ricky N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2020-11-23       Impact factor: 4.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.